MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer
26 Junio 2024 - 3:01PM
MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today
announced the appointment of Kim Moller to Chief Commercial
Officer. Ms. Moller has been serving as the Company’s Senior Vice
President, Sales since August 2020.
“I am pleased to announce this well-deserved promotion of Kim to
Chief Commercial Officer for MIMEDX,” stated Joseph H. Capper,
MIMEDX Chief Executive Officer. “Under Kim’s leadership as SVP of
Sales for the past four years, the MIMEDX commercial organization
has navigated significant change and has been transformed into the
high-performing team we have today. As we continue to work our way
through a period of sweeping change both in our industry and our
company, I could not imagine a more talented leader to guide all of
our commercial efforts.”
Mr. Capper continued, “With today’s announcement, Kim is
expanding her area of responsibility to include marketing and
international commercial operations, where we will continue to
benefit from her guidance. I look forward to working alongside of
Kim and the rest of the MIMEDX team as we continue the process of
building MIMEDX into a world class MedTech company.”
Ms. Moller boasts nearly three decades of experience in sales
leadership roles, having successfully executed strategic growth
plans for leading healthcare companies, including 3M and its
subsidiaries Acelity and KCI. Ms. Moller holds a B.S. in Nursing
(BSN) from University of Phoenix and an MBA from Colorado Christian
University.
About MIMEDXMIMEDX is a pioneer and leader
focused on helping humans heal. With more than a decade of helping
clinicians manage chronic and other hard-to-heal wounds, MIMEDX is
dedicated to providing a leading portfolio of products for
applications in the wound care, burn, and surgical sectors of
healthcare. The Company’s vision is to be the leading global
provider of healing solutions through relentless innovation to
restore quality of life. For additional information, please visit
www.mimedx.com.
Contact:Matt NotarianniInvestor
Relations470-304-7291mnotarianni@mimedx.com
MiMedx (NASDAQ:MDXG)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
MiMedx (NASDAQ:MDXG)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025